Correction to Benefits of Early Versus Late Initiation of Intravenous Immunoglobulin in the Treatment of Patients With Anti–3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy

IF 3.7 2区医学 Q1 RHEUMATOLOGY

Arthritis Care & Research Pub Date : 2025-02-03 DOI:10.1002/acr.25496

引用次数: 0

Abstract

Sharf K, Do T, Ghetie D, Choi D, Chahin N. Benefits of Early Versus Late Initiation of Intravenous Immunoglobulin in the Treatment of Patients With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy. Arthritis Care Res (Hoboken). 2024 Nov;76(11):1584-1592. doi: 10.1002/acr.25406.

In Table 2, all values for serum CK should be reported in units per liter (U/L), not L/L as mistakenly published. See below for the corrected Table 2.

Thank you for correcting this,

Kyle Sharf, DO

Nizar Chahin, MD

查看原文本刊更多论文

纠正静脉注射免疫球蛋白治疗抗3-羟基-3-甲基戊二酰辅酶A还原酶免疫介导的坏死性肌病的早期和晚期的益处。

肖建军，张建军，张建军，等。抗-3-羟甲基戊二酰辅酶A还原酶免疫介导坏死性肌病早期静脉注射免疫球蛋白的疗效分析。关节炎护理中心（霍博肯）。2024年11月,76(11):1584 - 1592。doi: 10.1002 / acr.25406。在表2中，所有血清CK值应以单位每升（U/L）报告，而不是错误公布的L/L。更正后的表2见下文。谢谢你的纠正，Kyle Sharf, DONizar Chahin， MD

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Arthritis Care & Research RHEUMATOLOGY-

CiteScore

9.40

自引率

6.40%

发文量

368

审稿时长

3-6 weeks

期刊介绍： Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals (a division of the College), is a peer-reviewed publication that publishes original research, review articles, and editorials that promote excellence in the clinical practice of rheumatology. Relevant to the care of individuals with rheumatic diseases, major topics are evidence-based practice studies, clinical problems, practice guidelines, educational, social, and public health issues, health economics, health care policy, and future trends in rheumatology practice.